BALLARD PARTNERS

Lobbying for GENETIX BIOTHERAPEUTICS INC. · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $120,000.00 income · posted Apr 15, 2026

Lobbying activity 1

Health Issues

Advocacy regarding an FDA issue.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem